Natural Capsules Ltd

Natural Capsules Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Natural Capsules Ltd

₹ 298 6.98%
22 Nov - close price
naturalcapsules.com BSE: 524654
About

Incorporated in 1993, Natural Capsules manufactures Capsules and Steroidal APIs and their Intermediates and Derivatives[1]

Key Points

Business Overview:[1][2][3]
NCL is a WHO-GMP certified and ISO 9001, ISO 140001 compliance manufacturer of printed and unprinted hard two-piece Gelatin and Cellulose (HPMC : non-animal alternative) capsules for pharmaceutical and dietary supplement industries in various sizes of 00, 0el, 0, 1, 2, 3 & 4. Apart from this, NCL has forayed into API manufacturing with complex high-end patented technology developed in-house, under its subsidiary company Natural Biogenex Private Limited.

Website BSE
  • Market Cap ₹ 308 Cr.
  • Current Price ₹ 298
  • High / Low ₹ 403 / 255
  • Stock P/E 53.3
  • Book Value ₹ 160
  • Dividend Yield 0.00 %
  • ROCE 8.43 %
  • ROE 6.10 %
  • Face Value ₹ 10.0
Edit ratios

Pros

Cons

  • Promoter holding has decreased over last quarter: -4.96%
  • Company has a low return on equity of 13.4% over last 3 years.
  • Debtor days have increased from 103 to 127 days.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Bulk Drugs & Formln

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024
30.20 37.61 41.55 44.19 45.06 45.50 38.12 37.70 37.52 38.38 40.20 39.14 41.03
24.86 29.91 33.37 35.01 35.40 35.80 31.23 31.64 32.28 33.44 35.70 34.41 36.09
Operating Profit 5.34 7.70 8.18 9.18 9.66 9.70 6.89 6.06 5.24 4.94 4.50 4.73 4.94
OPM % 17.68% 20.47% 19.69% 20.77% 21.44% 21.32% 18.07% 16.07% 13.97% 12.87% 11.19% 12.08% 12.04%
0.10 0.06 0.73 0.21 0.04 0.01 0.81 0.58 0.61 0.71 1.26 0.76 0.77
Interest 0.46 0.57 0.67 0.62 0.72 0.95 1.27 1.21 1.15 1.20 1.38 1.46 1.54
Depreciation 1.23 1.25 1.39 1.63 1.95 1.74 1.86 2.11 2.16 2.16 2.14 2.09 2.16
Profit before tax 3.75 5.94 6.85 7.14 7.03 7.02 4.57 3.32 2.54 2.29 2.24 1.94 2.01
Tax % 29.87% 30.47% 25.69% 26.61% 24.04% 25.21% 26.26% 25.90% 22.44% 25.76% 24.55% 24.74% 54.23%
2.63 4.13 5.09 5.24 5.34 5.25 3.37 2.46 1.97 1.70 1.69 1.46 0.92
EPS in Rs 2.83 4.44 5.47 5.63 5.74 5.65 3.68 2.65 2.12 1.82 1.81 1.56 0.90
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 TTM
53 59 67 62 54 55 60 62 80 135 171 153 159
42 47 56 52 49 49 55 56 68 109 135 133 140
Operating Profit 11 11 12 10 5 6 5 5 11 26 36 21 19
OPM % 21% 19% 17% 16% 10% 10% 8% 9% 14% 19% 21% 14% 12%
1 1 1 1 0 1 1 1 3 1 1 3 4
Interest 1 1 1 1 1 0 1 1 1 2 4 5 6
Depreciation 3 4 4 4 4 4 3 4 4 5 7 9 9
Profit before tax 7 7 8 6 0 2 2 1 9 19 26 10 8
Tax % 13% 39% 25% 28% -103% 34% 7% 38% 24% 28% 25% 25%
6 5 6 4 1 1 2 1 7 14 19 8 6
EPS in Rs 9.31 6.08 7.15 4.99 0.68 1.19 2.06 0.92 7.47 15.00 20.96 8.38 6.09
Dividend Payout % 11% 17% 14% 20% 99% 56% 32% 43% 9% 5% 5% 0%
Compounded Sales Growth
10 Years: 10%
5 Years: 21%
3 Years: 25%
TTM: 0%
Compounded Profit Growth
10 Years: 6%
5 Years: 30%
3 Years: 14%
TTM: -56%
Stock Price CAGR
10 Years: 16%
5 Years: 48%
3 Years: 17%
1 Year: -14%
Return on Equity
10 Years: 9%
5 Years: 11%
3 Years: 13%
Last Year: 6%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Sep 2024
Equity Capital 4 5 5 6 6 6 6 6 6 7 9 9 10
Reserves 32 37 42 48 48 48 49 49 56 76 115 123 154
10 6 5 6 3 0 5 6 10 33 49 62 54
9 11 11 18 14 19 14 14 26 28 38 37 46
Total Liabilities 56 59 63 77 71 73 75 76 98 144 211 231 264
29 31 29 30 26 22 24 24 35 63 93 91 88
CWIP 3 2 2 0 0 1 2 2 3 1 0 2 3
Investments 0 0 0 5 5 5 5 6 0 0 20 23 23
24 26 32 42 40 45 43 45 60 80 98 116 150
Total Assets 56 59 63 77 71 73 75 76 98 144 211 231 264

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
7 7 5 3 2 5 2 7 6 5 20 5
-5 -4 -4 -8 -0 -1 -7 -6 -9 -30 -55 -11
-2 -3 -1 4 -2 -4 4 -1 3 27 34 7
Net Cash Flow 0 0 -0 0 0 0 -1 0 -0 1 -1 2

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Debtor Days 117 118 125 167 191 208 197 180 123 71 111 127
Inventory Days 62 53 66 147 119 149 87 89 82 34 43 83
Days Payable 82 70 74 148 159 185 114 91 157 97 127 140
Cash Conversion Cycle 97 101 117 166 151 172 170 179 48 7 28 70
Working Capital Days 91 104 116 155 175 186 169 158 160 81 84 114
ROCE % 20% 18% 17% 12% 3% 4% 5% 4% 11% 23% 20% 8%

Shareholding Pattern

Numbers in percentages

1 Recently
Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
56.58% 56.57% 56.57% 56.57% 56.57% 56.57% 56.57% 56.57% 56.57% 56.57% 56.57% 51.59%
1.14% 1.22% 1.22% 1.22% 1.31% 1.31% 1.31% 1.31% 1.31% 1.31% 0.18% 0.00%
42.29% 42.21% 42.21% 42.23% 42.12% 42.13% 42.13% 42.13% 42.13% 42.13% 43.25% 48.39%
No. of Shareholders 5,5216,1187,1417,8778,2358,66610,80511,67511,39910,95410,5149,862

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Right Issue

Credit ratings

Concalls